BlackRock Fund Advisors’s Psychemedics Corporation PMD Stock Holding History

BlackRock Fund Advisors’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$329K	Buy	13,349 +658	+5%	+$14.7K	﹤0.01%	3309
2016 Q3	$252K	Sell	12,691 -506	-4%	-$9.38K	﹤0.01%	3377
2016 Q2	$181K	Sell	13,197 -6,463	-33%	-$89.8K	﹤0.01%	3486
2016 Q1	$270K	Sell	19,660 -1,631	-8%	-$18.7K	﹤0.01%	3368
2015 Q4	$216K	Buy	21,291 +395	+2%	+$4.3K	﹤0.01%	3500
2015 Q3	$210K	Buy	20,896 +1,214	+6%	+$14.1K	﹤0.01%	3445
2015 Q2	$292K	Sell	19,682 -2,023	-9%	-$31.5K	﹤0.01%	3378
2015 Q1	$360K	Sell	21,705 -1,472	-6%	-$23K	﹤0.01%	3328
2014 Q4	$351K	Buy	23,177 +1,656	+8%	+$24K	﹤0.01%	3330
2014 Q3	$305K	Sell	21,521 -1,564	-7%	-$22.2K	﹤0.01%	3324
2014 Q2	$327K	Buy	23,085 +650	+3%	+$9.87K	﹤0.01%	3313
2014 Q1	$384K	Buy	22,435 +985	+5%	+$16.3K	﹤0.01%	3295
2013 Q4	$315K	Buy	21,450 +900	+4%	+$12.4K	﹤0.01%	3308
2013 Q3	$272K	Buy	20,550 +3,020	+17%	+$37.5K	﹤0.01%	3295
2013 Q2	$188K	Buy	+17,530	New	+$197K	﹤0.01%	3343

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BlackRock Fund Advisors's PMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Psychemedics Corporation (PMD) stake by 5.2% in Q4 2016, buying an estimated $14.7K and bringing the position to 13,349 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

BlackRock Fund Advisors first reported a position in PMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $384K in Q1 2014. 52 funds tracked by Wall St. Rank hold PMD as of Q4 2016.

BlackRock Fund Advisors held 13,349 shares of Psychemedics Corporation worth $329K as of Q4 2016.
BlackRock Fund Advisors bought 658 Psychemedics Corporation shares in Q4 2016, an estimated $14.7K.
Psychemedics Corporation made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3309 holding.
BlackRock Fund Advisors first reported a position in Psychemedics Corporation in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Psychemedics Corporation position peaked at $384K in Q1 2014.
52 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.